Format

Send to

Choose Destination
See comment in PubMed Commons below
Curr Opin Investig Drugs. 2006 Feb;7(2):172-9.

Veronate (Inhibitex).

Author information

1
University of Virginia Health System, Department of Pediatrics, Charlottesville 22908, USA. DAK4R@virginia.edu

Abstract

Inhibitex, under license from BioResearch, is developing Veronate, an antibody-based immunotherapy for the potential prevention of Staphylococcus epidermidis, Staphylococcus aureus and Candida infections in very-low-birth-weight infants. Phase III clinical trials of Veronate are ongoing.

PMID:
16499288
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments

    Supplemental Content

    Loading ...
    Support Center